Source: Lancet gastroenterology & hepatology. Unidade: FM
Subjects: HEPATITE B, DIAGNÓSTICO CLÍNICO, HEPATITE VIRAL HUMANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAZAVI-SHEARER, Devin e CORREA, Maria C. Mendes. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet gastroenterology & hepatology, v. 3, n. 6, p. 383-403, 2018Tradução . . Disponível em: https://doi.org/10.1016/S2468-1253(18)30056-6. Acesso em: 24 abr. 2024.APA
Razavi-shearer, D., & Correa, M. C. M. (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet gastroenterology & hepatology, 3( 6), 383-403. doi:10.1016/S2468-1253(18)30056-6NLM
Razavi-shearer D, Correa MCM. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study [Internet]. Lancet gastroenterology & hepatology. 2018 ; 3( 6): 383-403.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/S2468-1253(18)30056-6Vancouver
Razavi-shearer D, Correa MCM. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study [Internet]. Lancet gastroenterology & hepatology. 2018 ; 3( 6): 383-403.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/S2468-1253(18)30056-6
